Unknown

Dataset Information

0

Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?


ABSTRACT:

Background

Cerebrospinal fluid (CSF) amyloid-beta (A?) 42/40 ratio, threonine-181-phosphorylated-tau (p-tau), and total-tau (t-tau) represent core biomarkers of Alzheimer disease (AD). The recent availability of automated platforms has represented a significant achievement for reducing the pre-analytical variability of these determinations in clinical setting. With respect to classical manual ELISAs, these platforms give us also the possibility to measure any single sample and to get the result within approximately 30?min. So far, reference values have been calculated from measurements obtained in frozen samples. In this work, we wanted to check if the values obtained in fresh CSF samples differ from those obtained in frozen samples, since this issue is mandatory in routine diagnostic work.

Methods

Fifty-eight consecutive CSF samples have been analyzed immediately after lumbar puncture and after 1-month deep freezing (-?80?°C). As an automated platform, we used Lumipulse G600-II (Fujirebio Inc.). Both the fresh and the frozen aliquots were analyzed in their storage tubes.

Results

In fresh samples, a mean increase of A?40 (6%), A?42 (2%), p-tau (2%), and t-tau (4%) was observed as compared to frozen samples, whereas a slight decrease was observed for A?42/A?40 ratio (4%), due to the higher deviation of A?40 in fresh samples compared to A?42. These differences are significant for A?40, A?42/A?40 ratio, p-tau, and t-tau. Nevertheless, the A?42/A?40 ratio showed a lower variability (smaller standard deviation of relative differences) with respect to A?42. With respect to the AD profile according to the A/T/(N) criteria for AD diagnosis, no significant changes in classification were observed when comparing results obtained in fresh vs frozen samples.

Conclusions

Small but significant differences have been found for A?40, A?42/A?40 ratio, p-tau, and t-tau in fresh vs frozen samples. Importantly, these differences did not imply a modification in the A/T/(N) classification system. In order to know if different cutoffs for fresh and frozen samples are required, larger, multi-center investigations are needed.

SUBMITTER: Bellomo G 

PROVIDER: S-EPMC7526419 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?

Bellomo Giovanni G   Cataldi Samuela S   Paciotti Silvia S   Paolini Paoletti Federico F   Chiasserini Davide D   Parnetti Lucilla L  

Alzheimer's research & therapy 20200929 1


<h4>Background</h4>Cerebrospinal fluid (CSF) amyloid-beta (Aβ) 42/40 ratio, threonine-181-phosphorylated-tau (p-tau), and total-tau (t-tau) represent core biomarkers of Alzheimer disease (AD). The recent availability of automated platforms has represented a significant achievement for reducing the pre-analytical variability of these determinations in clinical setting. With respect to classical manual ELISAs, these platforms give us also the possibility to measure any single sample and to get the  ...[more]

Similar Datasets

2016-10-19 | GSE83924 | GEO
| S-EPMC6746779 | biostudies-literature
| S-ECPF-GEOD-19249 | biostudies-other
| S-EPMC5910432 | biostudies-literature
2022-12-25 | GSE221571 | GEO
2020-05-08 | E-MTAB-9001 | biostudies-arrayexpress
| S-EPMC4488430 | biostudies-literature
| S-EPMC4671711 | biostudies-literature
| S-EPMC5266269 | biostudies-literature
| S-ECPF-TABM-1081 | biostudies-other